prenylamine has been researched along with Cardiomyopathies, Primary in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (90.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdel-Qadir, H; Amir, E; Fazelzad, R; Lee, DS; Ong, G; Thavendiranathan, P; Tomlinson, G | 1 |
Bolomo, NJ; Marantz, A; Milei, J | 1 |
Bolomo, N; Milei, J; Vazquez, A | 1 |
Jasmin, G; Solymoss, B | 1 |
Fleckenstein, A; Janke, J; Sigel, H | 1 |
Alé, J; Buceta, JE; Marantz, A; Milei, J; Vazquez, A | 1 |
Boveris, A; Llesuy, S; Milei, J; Milei, SE; Molina, H; Storino, R | 1 |
Döring, HJ; Fleckenstein, A; Janke, J; Leder, O | 1 |
Döring, HJ; Fleckenstein, A; Janke, J; Pachinger, O | 1 |
Schmitt, G | 1 |
1 review(s) available for prenylamine and Cardiomyopathies, Primary
Article | Year |
---|---|
Interventions for preventing cardiomyopathy due to anthracyclines: a Bayesian network meta-analysis.
Topics: Acetylcysteine; Adrenergic beta-Antagonists; Angiotensins; Anthracyclines; Cardiomyopathies; Clinical Trials as Topic; Dexrazoxane; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neoplasms; Network Meta-Analysis; Prenylamine; Ventricular Dysfunction, Left | 2017 |
1 trial(s) available for prenylamine and Cardiomyopathies, Primary
Article | Year |
---|---|
Prevention of adriamycin-induced cardiotoxicity by prenylamine: a pilot double blind study.
Topics: Aged; Cardiomyopathies; Doxorubicin; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Neoplasms; Prenylamine; Prospective Studies; Random Allocation | 1987 |
8 other study(ies) available for prenylamine and Cardiomyopathies, Primary
Article | Year |
---|---|
Prenylamine inhibition of adriamycin-induced cardiomyopathy in mice.
Topics: Animals; Antibiotics, Antineoplastic; Calcium Channel Blockers; Cardiomyopathies; Dose-Response Relationship, Drug; Doxorubicin; Female; Male; Mice; Prenylamine; Random Allocation | 1982 |
Effects of a CA-antagonist (prenylamine) on isoproterenol-induced myocardial lesions in the monkey (Cebus paraguayenses). Electrocardiographic and anatomopathological findings.
Topics: Animals; Calcium; Cardiomyopathies; Cytoskeleton; Electrocardiography; Female; Haplorhini; Heart Rate; Isoproterenol; Male; Myocardial Contraction; Myocardium; Myofibrils; Prenylamine | 1979 |
Prevention of hereditary cardiomyopathy in the hamster by verapamil and other agents.
Topics: Animals; Body Weight; Calcium; Cardiomyopathies; Cell Membrane; Cinnarizine; Creatine Kinase; Cricetinae; Electrolytes; Female; Gluconates; Male; Muscles; Myocardium; Prenylamine; Verapamil | 1975 |
Restriction of isoproterenol-induced myocardial Ca uptake and necrotization in rats by a new Ca-antagonistic compound (ethyl-4-(3,4,5-trimethoxycinnamoyl) piperazinyl acetate (Vascordil)).
Topics: Animals; Biological Transport; Calcium; Cardiomyopathies; Cinnamates; Dose-Response Relationship, Drug; Gallopamil; Isoproterenol; Myocardium; Necrosis; Piperazines; Prenylamine; Rats; Verapamil | 1975 |
Prenylamine inhibition of adriamycin-induced myocardiopathy.
Topics: Animals; Cardiomyopathies; Doxorubicin; Electrocardiography; Female; Male; Myocardium; Prenylamine; Rabbits | 1985 |
Myocardial fiber necrosis due to intracellular Ca overload-a new principle in cardiac pathophysiology.
Topics: Ammonium Chloride; Animals; Biological Transport; Calcitonin; Calcium; Cardiomyopathies; Dihydrotachysterol; Dose-Response Relationship, Drug; Drug Synergism; Guinea Pigs; Heart; Hydrogen-Ion Concentration; Isoproterenol; Magnesium; Myocardium; Necrosis; Phosphates; Potassium; Prenylamine; Rats; Verapamil | 1974 |
Ca overload as the determinant factor in the production of catecholamine-induced myocardial lesions.
Topics: Adenosine Triphosphate; Animals; Calcium; Cardiomyopathies; Dihydrotachysterol; Heart; Hydrocortisone; Isoproterenol; Magnesium; Myocardium; Phosphates; Phosphocreatine; Potassium Chloride; Prenylamine; Rats; Time Factors; Verapamil | 1973 |
[Prenylamine (Segontin) in hypertonically-caused myocardial diseases in animal experiments].
Topics: Animals; Cardiomyopathies; Electrocardiography; Hypertension, Renal; Hypoxia; Prenylamine; Rabbits | 1967 |